Dynakin

Name

Dynakin

Website

https://dynakin.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Contract Research Organization (Drug Development Services)

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industries

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

Keywords

• Contract research organization
• GLP biolab
• Drug development services
• Model-based drug development
• Preclinical research

Headquarters

HQ city

Derio

HQ country

Spain

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

Dynakin is a contract research organization (CRO) operating a GLP-compliant biolab and providing model-based drug development services. It supports pharmaceutical and biotech clients with laboratory and quantitative drug development work.

Differentiator

Problem solved

Functional benefit

Products and services

• GLP Biolab Services Good Laboratory Practice (GLP) compliant biolaboratory services supporting pharmaceutical and biotech clients in drug research.
• Model-Based Drug Development Services Model-based (quantitative) drug development services provided as a contract research organization to support pharmaceutical development programs.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Certara: Listed global leader in model-informed drug development and biosimulation, offering PBPK, PK/PD, and regulatory-grade modeling services. Directly comparable to Dynakin's model-based drug development offering but at materially greater scale and with proprietary software platforms.
• Inotiv: US preclinical CRO offering GLP bioanalytical, PK, and toxicology services with a similar boutique-to-mid scale. Directly comparable in service mix to the laboratory side of Dynakin's offering.
• Evidera (PPD / Thermo Fisher): Health economics, outcomes research, and modeling division within PPD/Thermo Fisher, offering model-based drug development and regulatory submission modeling. Comparable service portfolio to Dynakin's modeling capability, though embedded in a much larger CRO platform.
• Metrum Research Group: Boutique US CRO specializing in pharmacometric and PK/PD modeling services for regulatory submissions. Closely comparable to Dynakin in scale and niche focus on model-based drug development for small and mid-sized biopharma sponsors.
• Simulations Plus: US-listed provider of modeling and simulation software plus contract services for PBPK, PK/PD, and QSP work. Directly competes with Dynakin's modeling services and shares the same customer base of pharma modelers and regulatory scientists.

Regional players

• Citoxlab (now part of Charles River): Preclinical CRO originally based in France with strong European GLP bioanalytical and safety assessment operations. Comparable to Dynakin as a European-headquartered preclinical services provider before its integration into Charles River.

Broad incumbents

• Charles River Laboratories: Large preclinical CRO with GLP-compliant bioanalytical laboratories worldwide. Overlaps with Dynakin on the GLP bioanalytical lab side and on early-stage drug development services, though Charles River is far broader and offers discovery-to-manufacturing coverage.
• SGS Health & Nutrition: Global GLP testing and bioanalytical services provider serving pharma clients across early-stage development. Overlaps with Dynakin's GLP bioanalytical lab services, though SGS operates a much broader testing portfolio across many industries.
• Eurofins Scientific: Global testing services group with extensive GLP-compliant bioanalytical and pharmacokinetics labs across Europe, including Spain. Comparable to Dynakin's GLP lab offering within a vastly larger network; Eurofins' Spanish footprint in particular overlaps with Dynakin's geographic base.

Emerging players

• Pharmathen / Lambda Therapeutic Research: Mid-sized European clinical and preclinical research services provider with growing model-based drug development capabilities. Comparable in size and service scope to Dynakin as an emerging European CRO building modeling and bioanalytical offerings.

Market position

Customer concentration

• LinkedInlinkedin.com/company/dynakin-s.l.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dynakin